by Ellie Kroeger | Oct 14, 2026
What is dysautonomia? Dysautonomia, also known as “autonomic dysfunction,” is the improper functioning of the autonomic nervous system. Rather than a diagnosis itself, dysautonomia is an umbrella term, frustratingly vague in the scope of symptoms and diagnoses it...
by Stacey Johnson | Oct 2, 2026
As someone who regularly consumes broadcast and print news, I can confirm that coverage, analysis and opinion pieces on artificial intelligence (AI) are everywhere. AI is coming for our jobs, but it will also happily recommend a new one for us. AI has the potential to...
by Stacey Johnson | Sep 18, 2026
I went down a bit of a rabbit hole the other day, as one often does on the internet and/or social media. In my defence, I was looking for inspiration for my next blog post – this one – and I found some. It started with this parody song about placebos, by anesthetist...
by Stacey Johnson | Sep 4, 2026
Two articles in an August issue of The Globe and Mail caught my attention. The articles were very different – one was in the news section and one was in business – but they converged on a similar theme: women’s health. Women’s health has been under-researched,...
by Stacey Johnson | Aug 7, 2026
What are peptides and why are they all over traditional and social media? Peptides are chains of molecules called amino acids that link together; they are smaller versions of proteins. Thousands of naturally occurring peptides have been identified in the human body....
by Stacey Johnson | Jul 23, 2026
“Regulatory approval does not translate to dollars for a company, nor does it lead to patients being treated. Without reimbursement, all of the efforts of translation and development are lost.” My former colleague, Mark Curtis, wrote these words back when he blogged...
by Stacey Johnson | Jul 9, 2026
Celebrity health stories often dominate headlines, but their impact extends beyond entertainment news. High-profile diagnoses can raise awareness of rare diseases, increase participation in clinical trials, influence health policy, and accelerate investment in...
by Lyla El-Fayomi | Jun 24, 2026
Patients diagnosed with degenerative eye disorders, such as retinitis pigmentosa (RP) or choroideremia, face a gradual loss of light-sensing cells that eventually leads to blindness. Historically, most treatments could only aim to slow disease progression; however,...
by Michael May | Jun 9, 2026
Fifteen years ago, regenerative medicine in Canada stood at an inflection point. The science was world-class, the academic talent was undeniable, and the promise of cell and gene therapies was beginning to capture global attention. Yet there was a critical problem:...
Comments